Seeking men and women with Amyotrophic Lateral Sclerosis (ALS) who have decided with their doctor to start taking the drug Edaravone to slow their symptom progression for a study of what changes happen in the blood and urine after they start taking the drug.
We are studying changes in the blood and urine called biomarkers in people who take the drug Edaravone for their ALS. Every participant in this trial will be taking the drug Edaravone to slow their ALS symptom progression.
What we're hoping for
We hope to learn how the drug Edaravone affects the blood and urine of different people with Amyotrophic Lateral Sclerosis (ALS). The drug Edaravone has been approved by the FDA to slow ALS symptom progression.
ClinicalTrials.gov Identifier: NCT04259255